RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Geneos Wealth Management Inc.'s Holding History (CIK: 0001764754)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 350 Value ($000) $2 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 439 Value ($000) $2 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 439 Value ($000) $2 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 550 Value ($000) $4 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 350 Value ($000) $2 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 350 Value ($000) $3 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 350 Value ($000) $3 Avg Close $11.14 Range $8.68 - $15.74